{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:46:03Z","timestamp":1777934763230,"version":"3.51.4"},"reference-count":17,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This study evaluated the efficacy and safety of 3 mitomycin C (MMC) delivery methods in trabeculectomy for uncontrolled primary open-angle glaucoma (POAG): preoperative subconjunctival injection, intraoperative subconjunctival injection, and conventional soaked sponges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this randomized controlled pilot study, 25 patients were assigned to 3 groups: Group A received a preoperative subconjunctival injection of 0.1 mL MMC 0.002% 2 weeks before surgery; Group B received an intraoperative subconjunctival injection of 0.1 mL MMC 0.01%; and Group C received MMC 0.02% via soaked sponges during surgery. Patients were followed for 6 months. Primary outcome was surgical success\u2014complete [intraocular pressure (IOP) 5\u201321 mm Hg with \u226530% reduction from baseline without medications] or qualified (with medications). Secondary outcomes included IOP, medication use, best-corrected visual acuity, and complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      At 6 months, complete success rates were 75.0% (Group A), 66.7% (Group B), and 50.0% (Group C) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.54). Mean baseline IOP was 17.40\u2009\u00b1\u20094.43 mm Hg with 3.64\u2009\u00b1\u20090.70 medications. Postoperative IOPs were 9.88\u2009\u00b1\u20092.70, 10.67\u2009\u00b1\u20094.06, and 10.38\u2009\u00b1\u20095.04 mm Hg in Groups A, B, and C, respectively (\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      0.92). Medication use postoperatively was lowest in Group A (0 \u00b1 0), compared to Groups B (0.7\u2009\u00b1\u20091.0) and C (0.4\u2009\u00b1\u20091.1) (\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      0.30). Visual outcomes and complication rates were similar across groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In this pilot study, all MMC delivery methods demonstrated comparable success rates, IOP reduction, and safety outcomes. Subconjunctival MMC injections show promise as a viable alternative to the conventional sponge application. However, due to the small sample size, further larger-scale studies are warranted to validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251391092","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:24:42Z","timestamp":1761182682000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Preoperative Subconjunctival Injection, Intraoperative Subconjunctival Injection, and Soaked Sponges as Mitomycin C Delivery Methods for Trabeculectomy with a 6-Month Follow-Up Period: A Randomized Controlled Pilot Study"],"prefix":"10.1177","author":[{"given":"Pradtana","family":"Hirunpatravong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nopphawan","family":"Uramphorn","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharnsook","family":"Kasemsup","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Caprioli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002897.pub2"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1998.14.491"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10028-1233"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2018.06.003"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000287"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_963_19"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.03.002"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1995.11.233"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.11.23"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(92)31992-x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(90)32456-9"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-1031-9"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2007.01147.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-199300240-00007"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309671"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.10.022"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.12.1771"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251391092","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251391092","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251391092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:33:50Z","timestamp":1777689230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251391092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":17,"alternative-id":["10.1177\/10807683251391092"],"URL":"https:\/\/doi.org\/10.1177\/10807683251391092","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"10807683251391092"}}